Your browser doesn't support javascript.
loading
Transplant-Amenable Hepatocellular Carcinoma in a Fontan Patient.
Rutledge, Brian Patrick; Devara, Anupama; Benjaram, Sindhuri; Judd, Stephanie; Ehrinpreis, Murray.
Afiliación
  • Rutledge BP; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Devara A; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Benjaram S; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Judd S; Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Ehrinpreis M; Wayne State University School of Medicine, Detroit, Michigan, USA.
Case Rep Gastroenterol ; 13(2): 275-279, 2019.
Article en En | MEDLINE | ID: mdl-31341459
The Fontan circulation alters a patient's physiology and imparts long-term risks related to chronically elevated systemic venous pressure. An increasing number of patients with Fontan physiology are surviving into adulthood and are at risk of hepatic sequalae. The ideal timeline and method of hepatic surveillance in the Fontan population remains to be defined. In this case, the patient was diagnosed with hepatocellular carcinoma more than 20 years after undergoing the Fontan procedure and was a candidate for combined heart-liver transplant. That her disease progressed prior to organ availability supports the argument for hepatic surveillance in this population.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Gastroenterol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Gastroenterol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza